Anteris Technologies Global Corp. (AVR) — Stock Score Summary

Anteris Technologies Global Corp. (AVR) has a MoatMap StockRank of 60/100 based on Quality (33/100), Value (35/100), and Momentum (77/100) factor scores. The current signal is HOLD. Anteris Technologies is an early-stage medical device company focusing on structural heart valves. While the technology is promising, it is pre-revenue, highly speculative, and lacks the proven cash flows and high ROIC required for our concentrated book.

Anteris Technologies Global Corp. is a medical device company developing innovative technologies for structural heart diseases, notably a biomimetic 3D single-piece aortic heart valve. Its proprietary ADAPT® tissue technology aims to enhance valve durability and performance, addressing a critical need for next-generation heart valve solutions. The company operates in a specialized high-growth med-tech niche, pending clinical trial success and regulatory approvals.

Key Financial Metrics

Price$9.47
Market Cap$854M
P/E (Forward)-9.85
Price/Book3.37
Return on Equity-59.2%
Debt/Equity1.34
Gross Margin74.3%
Operating Margin-4859.7%
Revenue Growth-11.2%
Free Cash Flow$-53M

Anteris Technologies Global Corp. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (Australia).

Frequently Asked Questions

What is Anteris Technologies Global Corp.’s (AVR) StockRank?
MoatMap’s StockRank for Anteris Technologies Global Corp. (AVR) is 60/100, with a Hold signal. It is a composite of Quality (33), Value (35), and Momentum (77) factor ranks across MoatMap’s 19,000+ stock universe.
Does Anteris Technologies Global Corp. have an economic moat?
Anteris Technologies Global Corp. (AVR) has a Quality factor score of 33/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Anteris Technologies Global Corp. a buy, hold, or sell?
MoatMap’s current signal for Anteris Technologies Global Corp. (AVR) is Hold, based on a StockRank of 60/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Anteris Technologies Global Corp. in?
Anteris Technologies Global Corp. (AVR) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (Australia).
Browse all ranked stocksAVR deep dive reportAI ChampionsHow we score stocksSense-check another stock